Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2025-12-30 @ 8:47 PM
Study NCT ID:
NCT01133756
Status:
TERMINATED
Last Update Posted:
2023-06-22
First Post:
2010-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125
Sponsor:
Eisai Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-09
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-21
First Submit QC Date:
None
Study First Post Date:
2010-05-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-16
Results First Submit QC Date:
None
Results First Post Date:
2016-12-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2013-05-29
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2023-06-16
Last Update Post Date:
2023-06-22
Last Update Post Date Type:
ACTUAL